Vincenzo De Falco

Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience

Pietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta et al. · Cancers · 2019 · 65 citations · Full text

Surgical Oncology, Cancer Pathology, Pathology +24

Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory <i>RAS</i> Wild-Type Metastatic Colorectal Cancer

Stefania Napolitano, Vincenzo De Falco, Giulia Martini et al. · JAMA Oncology · 2023 · 53 citations · Full text

Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression

Stefania Napolitano, Nunzia Matrone, A. L. Muddassir et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 38 citations · Full text

Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer

Pietro Paolo Vitiello, Giulia Martini, Luigi Mele et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 37 citations · Full text

Panitumumab plus trifluridine/tipiracil as anti‐<scp>EGFR</scp> rechallenge therapy in patients with refractory <scp><i>RAS</i></scp> wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase <scp>II VELO</scp> trial

Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco et al. · International Journal of Cancer · 2023 · 36 citations · Full text

Oncology, Overall Survival, Gastrointestinal Oncology +14